WASHINGTON D.C., July 9, 2019 – Baker Botts, L.L.P., a leading energy and technology law firm, today announced that firm client PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, has completed the previously announced acquisition of Perrigo Animal Health, a leading manufacturer of vet quality products for pet parents, from Perrigo Company plc (NYSE; TASE: PRGO) for $185 million in cash.
Baker Botts handled the antitrust matters for PetIQ on the deal.
To read the full PetIQ closing announcement, please click here.
The Baker Botts Team was led by Antitrust Group Chair Steve Weissman, assisted by Senior Associate Christine Ryu-Naya. Both are residents in the firm’s Washington D.C. office. The Baker Botts Team worked closely with Winston & Strawn, which handled the corporate aspects of the transaction for PetIQ.
ABOUT BAKER BOTTS L.L.P.
Baker Botts is an international law firm of approximately 725 lawyers practicing throughout a network of 14 offices around the globe. Based on our experience and knowledge of our clients' industries, we are recognized as a leading firm in the energy and technology sectors. Throughout our 179-year history, we have provided creative and effective legal solutions for our clients while demonstrating an unrelenting commitment to excellence. For more information, please visit bakerbotts.com.